Automated Medical Laboratories, Inc., Cross-Appellant v. Armour Pharmaceutical Company, Cross-Appellee

629 F.2d 1118, 30 Fed. R. Serv. 2d 886, 30 U.C.C. Rep. Serv. (West) 996, 1980 U.S. App. LEXIS 12513
CourtCourt of Appeals for the Fifth Circuit
DecidedNovember 6, 1980
Docket79-3663
StatusPublished
Cited by29 cases

This text of 629 F.2d 1118 (Automated Medical Laboratories, Inc., Cross-Appellant v. Armour Pharmaceutical Company, Cross-Appellee) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Automated Medical Laboratories, Inc., Cross-Appellant v. Armour Pharmaceutical Company, Cross-Appellee, 629 F.2d 1118, 30 Fed. R. Serv. 2d 886, 30 U.C.C. Rep. Serv. (West) 996, 1980 U.S. App. LEXIS 12513 (5th Cir. 1980).

Opinion

POLITZ, Circuit Judge:

Automated Medical Laboratories, Inc. (Auto) operated several plasmapheresis centers and sold the plasma collected to Armour Pharmaceutical Company (Armour), a Phoenix-based business engaged in the purchase and processing of raw plasma for human medical needs. A dispute has arisen between the parties as to the validity, reach and breach of their agreement, as well as to damages sustained by each party and the peripheral issue of pre-judgment interest. After a bench trial, the district court (1) awarded Auto damages for breach of contract in the amount of $678,027.96, (2) awarded Armour damages on its cross-complaint for breach of contract in the amount of $109,644.51, and (3) awarded Auto prejudgment interest and costs. We affirm in part, reverse in part, and remand.

We find little meaningful dispute in the material facts, although there is substantial dispute about their meaning and about the application of the controlling rules of law. Lloyd Rothenberg, President of Auto, and Ralph Eacret, the officer in charge of plasma purchases for Armour, had for several years entered into annual oral contracts by which Armour purchased essentially all of Auto’s product. The oral agreements were followed by purchase orders which Armour sent Auto at the beginning of each year. Each month Auto shipped Armour the production from its collection centers.

Based on the relationship which existed between the parties, and assurances by Armour of its interest in purchasing all plasma produced, Auto undertook an expansion program which included the opening of five new centers. 1 By late 1974, Armour *1121 was purchasing a minimum of 6,000 liters of plasma per month, the entire output of Auto’s six plasmapheresis centers. By January 1975, Auto’s monthly production capacity had reached 15,000 liters, a capability of which Armour was aware. On January 7,1975, Armour issued a purchase order for calendar year 1975, calling for 3,000 liters per month of “Flash Frozen Plasma” at a price of $42.50 per liter. Because of the dramatic reduction in volume Rothenberg promptly called Eacret and they agreed to meet in Phoenix to resolve their differences. In late January 1975, Rothenberg, Eacret, and another representative of Armour, all met in Phoenix. Eacret succinctly detailed the results of that meeting, testifying:

Well, as I recall, an agreement was reached where Automated Medical Labs would supply additional quantities of plasma on the purchase order [for the January to December 1975 period].
[A]t the meeting, Mr. Rothenberg did mention a quantity of 8000 liters per month [and] we agreed, verbally to purchase that quantity. (Emphasis added.)

Between January 7, 1975 and mid-April 1975, Armour accepted delivery of and paid the agreed price for 26,884 liters. Also during this period, Armour informed Auto that it could' no longer use “Flash Frozen Plasma,” but would accept “Normal Fresh Frozen Plasma” at a price of $40.50 per liter. Auto’s agreement to this modification was confirmed in writing.

In late March or early April 1975, Roger Bauer, Eacret’s assistant, called Rothenberg to advise that Armour would no longer accept any shipments, citing an excessive inventory and no market. On April 25, 1975, Armour sent Auto the following telegram:

AS DISCUSSED YOUR LAST PLASMA SHIPMENT TO ARMOUR UNTIL FURTHER NOTICE WILL BE DURING THE WEEK OF 4/21/75.

Armour never resumed purchases from Auto, who remained ready and able to supply 8,000 liters per month. In an effort to mitigate its dilemma, Auto secured a German customer who purchased 2,000 liters per month, commencing June 28, 1975. Auto ceased collecting plasma at three of its centers.

In June 1975, Armour was informed by the Bureau of Biologies, Food and Drug Administration (the Bureau) that five units (approximately 3 liters) of plasma shipped from Auto’s Orlando center in 1974 were possibly contaminated with hepatitis. Armour was also informed that plasma from both the Clearwater and Orlando facilities was under quarantine. Armour promptly notified Auto of this information and asserted' that the questioned plasma did not conform to the warranty specifications of their purchase agreement.

After completing its investigation, the Bureau informed Armour that all plasma from Auto’s Clearwater and Orlando centers which Armour had in process of manufacture as of June 6, 1975 was safe and could be sold. All such plasma “in process” had been shipped prior to January 1, 1975. Any resulting warranty breach, therefore, necessarily arose pursuant" to the terms of the parties’ 1974 contract and not the January 1975 Phoenix agreement.

Upon receiving approval from the Bureau on August 27, 1975, Armour tested over 28,000 units of the suspect plasma. Ninety-nine units of plasma tested “hepatitis positive.” Armour incurred expenses totaling $109,644.51 in its program to sample, test, store, and care for the quarantined plasma.

After weighing the evidence adduced at trial, the district court held: (1) that the January 1975 “Phoenix agreement,” requiring Armour to purchase 8,000 liters of plasma per month at $42.50 per liter, was a binding oral contract for the calendar year 1975; (2) that the contract price was mutually modified in March 1975 to $40.50 per liter; (3) that Armour breached and completely repudiated the contract in April 1975; (4) that Auto was entitled to recover *1122 net damages amounting to $678,027.96, as well as pre-judgment interest on this award; and (5) that due to Auto’s breach of warranty resulting from the hepatitis-contaminated blood, Armour sustained $109,-644.51 in damages, which amount was to be offset against Auto’s damage recovery, resulting in a net award to Auto of $568,-383.45.

On appeal, Armour contends that the Phoenix agreement is not a binding contract because it violates the statute of frauds and that Auto is not entitled to pre-judgment interest because its damages are unliquidated. Auto insists that the contract is binding, that it is entitled to gross damages, rather than net damages, and it challenges the breach of warranty recovery awarded Armour.

The Phoenix Agreement: Bad Contract as Well as Bad Blood?

U.C.C. § 2-201 2 provides that contracts for the sale of goods valued in excess of $500 are unenforceable unless in writing and signed by or for the respondent party. 3 Armour claims that the Phoenix agreement, providing for the- purchase/sale of 8,000 liters per month throughout 1975, is unenforceable under § 2-201 because it is not in writing.

Invoking the statute of frauds is an affirmative defense which must be specially pled. Fed.R.Civ.P. 8(c). Although absolute specificity in pleading is not required, fair notice of the affirmative defense is. Fed.R. Civ.P. 8(f).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Untitled Case
S.D. Mississippi, 2026
International Marine, L.L.C. v. FDT, L.L.C.
619 F. App'x 342 (Fifth Circuit, 2015)
Gedalia v. Whole Foods Market Services, Inc.
53 F. Supp. 3d 943 (S.D. Texas, 2014)
Weiss v. Allstate Insurance
512 F. Supp. 2d 463 (E.D. Louisiana, 2007)
Sanmina Corporation v. Banctec USA Inc
94 F. App'x 194 (Fifth Circuit, 2004)
In Re Snelson
305 B.R. 255 (N.D. Texas, 2003)
Government of Aruba v. Sanchez
216 F. Supp. 2d 1320 (S.D. Florida, 2002)
In Re Cudd Pressure Control, Inc.
109 F. Supp. 2d 486 (E.D. Louisiana, 2000)
Woodfield v. Bowman
Fifth Circuit, 1999
Cooperative Finance Ass'n, Inc. v. Garst
917 F. Supp. 1356 (N.D. Iowa, 1996)

Cite This Page — Counsel Stack

Bluebook (online)
629 F.2d 1118, 30 Fed. R. Serv. 2d 886, 30 U.C.C. Rep. Serv. (West) 996, 1980 U.S. App. LEXIS 12513, Counsel Stack Legal Research, https://law.counselstack.com/opinion/automated-medical-laboratories-inc-cross-appellant-v-armour-ca5-1980.